Apokyn FDA Approval History
FDA Approved: Yes (First approved April 20, 2004)
Brand name: Apokyn
Generic name: apomorphine
Dosage form: Injection
Company: Bertek Pharmaceuticals
Treatment for: Parkinson's Disease
Apokyn (apomorphine) is a non-ergoline dopamine agonist indicated for the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose wearing off" and unpredictable "on/off" episodes) associated with advanced Parkinson’s disease.
Development timeline for Apokyn
| Date | Article |
|---|---|
| Apr 20, 2004 | Approval Apokyn Bertek Pharmaceuticals - Treatment for Parkinson’s Disease |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
